The first chance to gauge any political support for that option may come this week, when CDC's Frieden testifies before a House subcommittee about the anthrax and flu releases. "I'm sure there will be many changes to come," said biosafety consultant Debra Sharpe. "I just hope they will be wel
Date: Jul 14, 2014
Category: Health
Source: Google
CDC Should Have Learned a Lesson from the Anthrax Scare Of 2004
The CDC biosafety practices have been questioned by Debra Sharpe, chief investigator of the Oakland incident. She feels that enough money is not being spent on training or implementing management systems.